Bank of America’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.79K Buy
2,904
+60
+2% +$99 ﹤0.01% 6267
2025
Q1
$3.78K Sell
2,844
-185
-6% -$246 ﹤0.01% 6213
2024
Q4
$5.66K Sell
3,029
-154,949
-98% -$290K ﹤0.01% 6163
2024
Q3
$123K Buy
157,978
+6
+0% +$5 ﹤0.01% 5367
2024
Q2
$118K Sell
157,972
-11,929
-7% -$8.95K ﹤0.01% 5355
2024
Q1
$180K Sell
169,901
-130
-0.1% -$138 ﹤0.01% 5098
2023
Q4
$179K Sell
170,031
-2,931
-2% -$3.08K ﹤0.01% 5214
2023
Q3
$194K Buy
172,962
+10,023
+6% +$11.2K ﹤0.01% 5059
2023
Q2
$245K Buy
162,939
+147,691
+969% +$222K ﹤0.01% 4887
2023
Q1
$23.8K Buy
15,248
+12,138
+390% +$18.9K ﹤0.01% 5901
2022
Q4
$1.98K Sell
3,110
-99,686
-97% -$63.5K ﹤0.01% 6421
2022
Q3
$136K Sell
102,796
-16,808
-14% -$22.2K ﹤0.01% 5389
2022
Q2
$265K Sell
119,604
-100,338
-46% -$222K ﹤0.01% 5158
2022
Q1
$1.36M Sell
219,942
-4,434
-2% -$27.4K ﹤0.01% 4301
2021
Q4
$2.83M Buy
224,376
+174,698
+352% +$2.2M ﹤0.01% 3613
2021
Q3
$4.55M Buy
49,678
+32,657
+192% +$2.99M ﹤0.01% 3137
2021
Q2
$903K Sell
17,021
-6,799
-29% -$361K ﹤0.01% 4324
2021
Q1
$859K Buy
23,820
+14,889
+167% +$537K ﹤0.01% 4396
2020
Q4
$248K Buy
8,931
+880
+11% +$24.4K ﹤0.01% 4758
2020
Q3
$403K Sell
8,051
-259
-3% -$13K ﹤0.01% 4304
2020
Q2
$384K Sell
8,310
-624
-7% -$28.8K ﹤0.01% 4290
2020
Q1
$407K Buy
8,934
+4,942
+124% +$225K ﹤0.01% 4125
2019
Q4
$224K Buy
3,992
+2,421
+154% +$136K ﹤0.01% 4796
2019
Q3
$39K Sell
1,571
-4,053
-72% -$101K ﹤0.01% 5567
2019
Q2
$239K Buy
+5,624
New +$239K ﹤0.01% 4798